FDA Inspection
FinVector OyFinVector Oy – FDA Inspection, May 28, 2024
Record Details
This FDA Inspection record concerns FinVector Oy, with an inspection on May 28, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 2c9beb12-0213-49b0-a4a4-80033db8bbe8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1239622
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 211.84(d)(3)Establish reliability of supplier's C of A
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of FinVector Oy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 4, 2026 | Not classified | Office of Inspections and Investigations |
Other documents for FinVector Oy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.